Determination of antitubercular drugs by micellar electrokinetic capillary chromatography (MEKC). 2002

M I Acedo-Valenzuela, and A Espinosa-Mansilla, and A Muñoz De La Peña, and F Cañada-Cañada
Department of Analytical Chemistry, Faculty of Science, University of Extremadura, Avda. de Elvas s/n, 06011-Badajoz, Spain. miacedo@unex.es

A method for the determination of isoniazid (ISO), pyrazinamide (PYR) and rifampicin (RIF) in pharmaceutical products, by micellar electrokinetic capillary chromatography (MEKC) with ultraviolet detection is described. The influence of pH, concentration of surfactants, buffer and organic solvents, over the separation were studied as experimental variables. The optimal separation was carried out at 30 degrees C and 20 kV, using a 40 mM borate buffer and 100 mM sodium dodecylsulphate (SDS) adjusted to pH 8.5. Under these conditions, the analysis is accomplished in about 8 min. The method was applied to the determination of these compounds in different pharmaceuticals with good results when compared with a reference liquid chromatographic (LC) method.

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D011718 Pyrazinamide A pyrazine that is used therapeutically as an antitubercular agent. Tisamid
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D020374 Chromatography, Micellar Electrokinetic Capillary A hybrid separation technique combining both chromatographic and electrophoretic separation principles. While the method was invented to separate neutral species, it can also be applied to charged molecules such as small peptides. MECC,MEKC,Micellar Electrokinetic Capillary Chromatography

Related Publications

M I Acedo-Valenzuela, and A Espinosa-Mansilla, and A Muñoz De La Peña, and F Cañada-Cañada
May 2016, Phytochemical analysis : PCA,
M I Acedo-Valenzuela, and A Espinosa-Mansilla, and A Muñoz De La Peña, and F Cañada-Cañada
August 1998, Talanta,
M I Acedo-Valenzuela, and A Espinosa-Mansilla, and A Muñoz De La Peña, and F Cañada-Cañada
August 1992, Journal of pharmaceutical and biomedical analysis,
M I Acedo-Valenzuela, and A Espinosa-Mansilla, and A Muñoz De La Peña, and F Cañada-Cañada
December 2006, Die Pharmazie,
M I Acedo-Valenzuela, and A Espinosa-Mansilla, and A Muñoz De La Peña, and F Cañada-Cañada
August 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
M I Acedo-Valenzuela, and A Espinosa-Mansilla, and A Muñoz De La Peña, and F Cañada-Cañada
March 2017, Molecules (Basel, Switzerland),
M I Acedo-Valenzuela, and A Espinosa-Mansilla, and A Muñoz De La Peña, and F Cañada-Cañada
November 1997, Cellular and molecular biology (Noisy-le-Grand, France),
M I Acedo-Valenzuela, and A Espinosa-Mansilla, and A Muñoz De La Peña, and F Cañada-Cañada
September 2000, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
M I Acedo-Valenzuela, and A Espinosa-Mansilla, and A Muñoz De La Peña, and F Cañada-Cañada
July 2001, Electrophoresis,
M I Acedo-Valenzuela, and A Espinosa-Mansilla, and A Muñoz De La Peña, and F Cañada-Cañada
May 2004, Analytical and bioanalytical chemistry,
Copied contents to your clipboard!